Health

  • June 16, 2026

    WestRock Must Face Class Claims Over Wash. Paper Mill Odor

    A group of Washington and Oregon residents can proceed with a proposed class action accusing paper mill operator WestRock Longview LLC of negligently releasing noxious gases that sickened neighbors and hurt property values, a Washington federal judge ruled Monday.

  • June 16, 2026

    J&J Fails To Undo $65.5M Verdict In Minn. Talc Cancer Case

    A Minnesota state judge on Monday upheld a $65.5 million verdict awarded to a mother of three children who had claimed that Johnson & Johnson's talc products exposed her to asbestos and contributed to her cancer, saying that the jury's decision was supported by the evidence at trial.

  • June 16, 2026

    Cigna Loses Privilege Bid Due To 'Inaccurate, Redundant' Log

    Cigna "improperly asserted privilege" over hundreds of documents that three laboratories sought as part of the discovery process in federal payment litigation in Connecticut, according to a special master appointed by the judge in the consolidated cases.

  • June 16, 2026

    Judge Allows Pfizer, Moderna Defenses In GSK Vax IP Dispute

    A Delaware federal judge on Tuesday permitted Pfizer and Moderna to move ahead with their arguments that GlaxoSmithKline patents the company claims are infringed by the COVID-19 vaccines are unenforceable because of an unreasonable delay in obtaining them.

  • June 16, 2026

    Anti-Abortion Group Renews Bid To Block NJ's Info Demand

    An anti‑abortion pregnancy center urged a federal judge to block New Jersey's attorney general from enforcing a subpoena seeking financial donor information, arguing in a renewed bid for a preliminary injunction that the demand is retaliatory and persists despite a U.S. Supreme Court ruling allowing the group to challenge the investigation.

  • June 16, 2026

    J&J Talc Trial In LA Ends With Deadlocked Jury

    A mistrial was declared Monday by a Los Angeles state judge in a two-month trial over allegations Johnson & Johnson's talc products caused a woman's deadly mesothelioma after the jury deadlocked during deliberations, according to counsel for the plaintiff.

  • June 16, 2026

    Md. Judge Continues Health Case Law Streak With ACA Ruling

    U.S. District Judge Brendan Abell Hurson in Baltimore has been on the bench for less than three years. He's already building an impressive list of healthcare rulings.

  • June 16, 2026

    Pfizer Agrees To Deal To End Depo-Provera MDL

    The plaintiffs in the multidistrict litigation accusing Pfizer of failing to warn consumers of a link between brain tumors and the hormonal contraceptive Depo-Provera have reached an agreement with the pharmaceutical giant, according to an order filed Monday.

  • June 16, 2026

    Academic Group Fights Feds' Bid For Lawsuit Funding Info

    The Association of American Universities told a Massachusetts federal court on Monday it should not be required to open its books to prove it's eligible to recover attorney fees for successfully defeating the U.S. Department of Health and Human Services' caps on indirect research costs last year.

  • June 16, 2026

    Remote Workers Tell 6th Circ. Boot-Up Time Compensable

    Remote call center workers handling inbound patient calls from home have argued before a Sixth Circuit panel that their employer failed to pay them in accordance with the Fair Labor Standards Act for pre-shift computer startup work integral to their jobs.

  • June 16, 2026

    FCC Urged To Revise Test Rule Language

    A trade group representing commercial, scientific and testing laboratories in the U.S. has asked the Federal Communications Commission to narrowly tailor the language of a planned rule that would restrict accreditation for labs that test communications equipment.

  • June 15, 2026

    Med Groups Slam HHS 'Red Herring' Bid To Fast-Track Appeal

    Medical groups who won an order halting the Trump administration's modified childhood vaccination schedule on Monday urged the First Circuit to ignore the U.S. Department of Health and Human Services' "red herring" arguments for an expedited appeal, saying the agency has for months stalled the process.

  • June 15, 2026

    Cognizant, Infosys Can't Shield Execs From Depositions

    Infosys Ltd. and Cognizant TriZetto Software Group Inc. will each have to produce executives to speak on certain topics for depositions in a Texas federal lawsuit over claims that Infosys stole Cognizant's trade secrets to build a competing healthcare software, a special master ruled Monday.

  • June 15, 2026

    DOJ Says NY Court Can't Block Texas Trans Records Probe

    The U.S. Department of Justice urged a New York federal court Monday to deny a request for an order barring the government from seeking transgender minor patients' medical records through a criminal subpoena issued by a Texas grand jury, arguing the court lacks jurisdiction.

  • June 15, 2026

    Attys Want Up To $33M In Long-Running UBH Benefits Fight

    Attorneys for employee benefit plan participants who sued to change how United Behavioral Health processed claims for mental health and substance use disorder treatment asked a California federal court for up to $33 million in fees and expenses for their work on the "groundbreaking" case.

  • June 15, 2026

    Psilocybin Home Access Wouldn't Alter Ore. Law, Court Told

    Allowing homebound patients to consume psilocybin at their residences would not fundamentally change an Oregon voter-approved program, licensed facilitators said Friday, urging a federal court to reject the state health authority's bid to end their disability bias lawsuit.

  • June 15, 2026

    Univ. Of Washington Beats Medical Prof's Bias Suit At Trial

    Jurors have cleared the University of Washington's medical school of liability in an anesthesiology professor's lawsuit alleging that she was unfairly ousted from a director role after complaining of discrimination and harassment, finding that the professor failed to sufficiently prove any of her three claims against the school.

  • June 15, 2026

    FTC Pulls OptumRx Insulin Price Case To Review Final Deal

    The Federal Trade Commission's third and final settlement resolving an in-house case accusing pharmacy benefit managers of inflating insulin prices through rebate schemes is in sight after the agency on Friday pulled from adjudication its allegations against UnitedHealth Group Inc.'s OptumRx to review a deal struck with staffers.

  • June 15, 2026

    Fed. Circ. Declines To Revive Medmix's Dentistry Patent

    The Patent Trial and Appeal Board didn't err when invalidating claims of a Medmix Switzerland AG patent used in the dentistry industry, the Federal Circuit said Monday.

  • June 15, 2026

    Hospital Co. Says Ex-CEO Siphoned $14M For Personal Use

    The former CEO of Healthcare Systems of America is facing a new lawsuit filed by several company entities in Florida state court that claims he used HSA as a personal piggy bank, transferring $14 million from corporate accounts to fund a lavish lifestyle.

  • June 15, 2026

    EEOC Strikes Tentative Deal To End Suit Over Ban On Beards

    The U.S. Equal Employment Opportunity Commission and emergency services provider Global Medical Response told a Colorado federal court they've reached an agreement to resolve the agency's lawsuit alleging that the company's strict no-beard policy violated federal laws.

  • June 15, 2026

    CareFirst Says Intent Standard Was Misread In Stelara Case

    CareFirst is arguing that a Virginia federal judge created a new standard for monopolization claims when he dismissed claims from the company's antitrust suit challenging Johnson & Johnson's protection of its immunosuppressive drug Stelara, arguing he misread a Fourth Circuit decision in ruling that monopolization requires a showing of specific intent.

  • June 15, 2026

    Patient Says Botched C-Section Anesthesia Left Her In 'Agony'

    A woman who underwent a cesarean section to deliver her second baby at Forbes Regional Hospital outside Pittsburgh says the anesthesia was improperly administered, leaving her "screaming in agony" during the procedure while doctors did nothing, according to a lawsuit in Pennsylvania state court made public Monday.

  • June 15, 2026

    GEO Says Only ICE Controls NJ Detention Center Access

    Private prison operator The GEO Group Inc. has told a New Jersey federal court it was wrongly sued over state health inspectors allegedly being blocked from fully accessing an immigration detention facility, arguing U.S. Immigration and Customs Enforcement exclusively controls access.

  • June 15, 2026

    J&J Wants Talc MDL Tossed After Plaintiffs Withdraw Experts

    Johnson & Johnson urged a New Jersey federal court to toss all the pending cases in the sprawling multidistrict litigation alleging that its talc products caused ovarian cancer after the plaintiffs withdrew their two "marquee" experts on the link between the disease and talc use.

Expert Analysis

  • Mass. Draft Regs Signal Nationwide Scrutiny Of Junk Fees

    Author Photo

    Massachusetts Attorney General Andrea Campbell's new draft regulations for assisted living facilities is only her latest move in the war on junk fees — and part of a national reordering of consumer protection enforcement in which states are aggressively and creatively asserting authority, says Steve Provazza at Arnall Golden.

  • 4 Emerging Approaches To AI Protective Order Language

    Author Photo

    Over the last year, at least five federal district courts have issued or analyzed specific protective order provisions restricting the use of generative artificial intelligence platforms with protected materials, establishing that proactive AI-specific provisions are now standard practice and demonstrating that no single model works for every case, says Joel Bush at Kilpatrick.

  • What Justices Are Focusing On In 'Skinny Label' Patent Case

    Author Photo

    Though Hikma v. Amarin appears to be a patent dispute that could reshape inducement doctrine in the pharmaceutical context, oral argument suggests the U.S. Supreme Court may treat this as primarily a pleading-stage dispute, with important unresolved questions lurking beneath the surface, says Shashank Upadhye at Upadhye Tang.

  • Accelerated Psychedelic Therapy Pathways Require Caution

    Author Photo

    President Donald Trump's new executive order aiming to accelerate the approval of psychedelic drugs for the treatment of mental health disorders will likely bolster investigational psychedelic therapies, but parties within the psychedelic product supply chain will still need to prepare for potentially burdensome compliance requirements, say attorneys at Morgan Lewis.

  • Heppner Ruling Left AI Privilege Risk For Lawyers Unresolved

    Author Photo

    While a New York federal judge’s recent ruling in U.S. v. Heppner resolved a privilege question surrounding client-side artificial intelligence use, it did not address how to mitigate the risks that can arise when confidential information enters the operative context of an AI system used by an attorney, says Jianfei Chen at Quarles & Brady​​​​​​​.

  • The Ethics And Practicalities Of Representing AI Agents

    Author Photo

    With autonomous artificial intelligence agents now able to take action without explicit instructions from — or the awareness of — their human owners, the bar must confront whether existing frameworks like informed consent and client privilege will be sufficient on the day an AI agent calls seeking counsel, say attorneys at Morrison Cohen.

  • Health Cos. Must Act Quickly To Secure Digital Front Doors

    Author Photo

    A fast-approaching deadline will require health providers to implement digital accessibility standards to their websites, necessitating important compliance steps that will help to ensure equal access to online health services, say attorneys at Holland & Knight.

  • Series

    Speed Jigsaw Puzzling Makes Me A Better Lawyer

    Author Photo

    My passion for speed puzzling — I can complete a 500-piece jigsaw puzzle in under 50 minutes — has sharpened my legal skills in more ways than one, with both disciplines requiring patience, precision and the ability to keep the bigger picture in mind while working through the details, says Tazia Statucki at Proskauer.

  • Documenting Business Purpose After IRS' 10th Circ. Win

    Author Photo

    Following the Tenth Circuit’s recent Liberty Global v. U.S. decision, which held the economic substance doctrine does not require a threshold relevancy determination, taxpayers can prepare for potential audits by maintaining contemporaneous documentation and taking other steps that demonstrate the business purpose of transactions, say attorneys at Crowell & Moring.

  • How Oregon Ruling Affects Federal Gender Care Crackdown

    Author Photo

    In a favorable development for healthcare providers, an Oregon federal court recently vacated certain U.S. Department of Health and Human Services restrictions on gender-affirming care for minors, but the government's broader campaign against this care, including proposed rulemaking and agency investigations, leaves significant uncertainty, say attorneys at Arnold & Porter.

  • Suit's Dismissal Would Not Settle Gold Card Visa's Legality

    Author Photo

    The government’s recent assertion that the plaintiffs in American Association of University Professors v. Department of Homeland Security lack standing to challenge the Trump administration’s pay-to-play immigration program does not address whether an agency can deem a million-dollar gift evidence of eligibility for immigration benefits carefully defined by Congress, says Jun Li at Reid & Wise.

  • 2 AI Snafus Show Why Attys Can't Outsource Judgment

    Author Photo

    The recent incident involving Sullivan & Cromwell where citations in a filed motion were fabricated by artificial intelligence, as well as a punitive ruling from the Sixth Circuit in U.S. v. Farris, demonstrate that the obligation to supervise AI has belonged and always will belong to lawyers, says John Powell at the Kentucky School Boards Association.

  • NY Opioid Antagonist Mandate Leaves Employers Guessing

    Author Photo

    A recently enacted New York law will require employers that are federally mandated to maintain first-aid supplies to now include an opioid antagonist, but being that it is subject to a complicated Occupational Safety and Health Administration analysis, employers face several unanswered compliance questions, say attorneys at Conn Maciel.

  • Calif. Case Raises Questions For Medical Practice Investors

    Author Photo

    The California attorney general's amicus brief in Art Center v. WCE and the California Medical Association's response highlight how the California appeals court's ruling could significantly affect the structure and enforceability of succession arrangements in medical practice ownership, say attorneys at Ropes & Gray.

  • Previewing FDA Preapproval Access In Psychedelics EO

    Author Photo

    The second of two pathways for psychedelic drug access outlined in President Donald Trump's recent executive order constitutes an unprecedented expansion of the Right to Try Act, which could fundamentally alter the psychedelic access landscape while presenting significant regulatory, operational and legal challenges, say attorneys at Husch Blackwell.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.